Free Trial
LON:DXRX

Diaceutics (DXRX) Share Price, News & Analysis

Diaceutics logo
GBX 124 -0.81 (-0.65%)
As of 10:40 AM Eastern

About Diaceutics Stock (LON:DXRX)

Key Stats

Today's Range
123
126
50-Day Range
108
140
52-Week Range
106
151
Volume
26,550 shs
Average Volume
122,449 shs
Market Capitalization
£104.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
GBX 160
Consensus Rating
Buy

Company Overview

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network®.

Receive DXRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Diaceutics and its competitors with MarketBeat's FREE daily newsletter.

DXRX Stock News Headlines

Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
Diaceutics (LON:DXRX) Shares Up 2.3% - Should You Buy?
See More Headlines

DXRX Stock Analysis - Frequently Asked Questions

Diaceutics' stock was trading at GBX 123 at the beginning of 2025. Since then, DXRX shares have increased by 0.8% and is now trading at GBX 124.
View the best growth stocks for 2025 here
.

Diaceutics PLC (LON:DXRX) announced its earnings results on Tuesday, May, 13th. The company reported ($2.02) EPS for the quarter. Diaceutics had a negative net margin of 10.90% and a negative trailing twelve-month return on equity of 7.15%.

Shares of DXRX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Diaceutics investors own include 4D pharma (DDDD), Rolls-Royce Holdings plc (RR.L), Abcam (ABC), B&M European Value Retail (BME), BP (BP), Coats Group (COA) and genedrive (GDR).

Company Calendar

Last Earnings
5/13/2025
Today
6/16/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
LON:DXRX
CIK
N/A
Phone
N/A
Fax
N/A
Employees
151
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 160
High Stock Price Target
GBX 160
Low Stock Price Target
GBX 160
Potential Upside/Downside
+29.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
122.68
P/E Growth
N/A
Net Income
-£2.84 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£26.08 million
Cash Flow
GBX 39.75 per share
Price / Cash Flow
3.12
Book Value
GBX 45.87 per share
Price / Book
2.70

Miscellaneous

Free Float
N/A
Market Cap
£104.65 million
Optionable
Not Optionable
Beta
0.58
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (LON:DXRX) was last updated on 6/16/2025 by MarketBeat.com Staff
From Our Partners